• Pharmacy Residency Program

    pharmacy clean room  

    The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related disease.

    The Pharmacy department maintains programs and practices to ensure safe, optimal, and cost effective drug therapy for Dana-Farber patients, while also supporting patient and provider drug education and patient care-oriented research.

    About the Pharmacy Residency Program

    The Pharmacy Residency Program is an ASHP-accredited PGY-2 oncology pharmacy residency designed to provide the resident with opportunities to develop clinical competence in oncology pharmacy practice. The resident will gain experience in the following areas of practice:

    • Adult ambulatory oncology
    • Inpatient medical and hematologic oncology
    • Inpatient stem cell transplant
    • Palliative care
    • Pediatric oncology
    • Medication safety
    • Investigational drug services
    • Grand rounds, tumor board, and other oncology related lectures

    Through these educational experiences, residents will:

    1. Demonstrate development as a role-model for clinical pharmacists in the oncology setting.
    2. Develop various teaching styles for application in a variety of settings, including experiential education, small group teaching, and group lecture.
    3. Collaborate with clinical pharmacy staff to provide educational resources for patients and practitioners.
    4. Develop skills in the areas of pharmacy administration, disease state management, drug information, synthesis and analysis of clinical information, and development of clinical care plans.
    5. Refine communication and time management skills.
    6. Develop, implement, and analyze data of a year-long, publishable research project.
    7. Incorporate self-directed learning and personal development through self reflection, evaluation, and feedback.

    Research projects

    Research projects will be determined according to the resident's interest and department needs. The resident will be required to complete one project to be presented at a national meeting (HOPA).

    Examples of past resident research projects:

    • 2013-2014
      • Evaluation of off-label oral chemotherapy: A pilot study
      • Off-label use of chemotherapy with limited evidence: An assessment of efficacy and safety
       
    • 2012-2013
      • Characterization and assessment of anti-cancer therapy used to treat elderly patients with gynecologic malignancies
      • Characteristics of hematopoietic stem cell transplant patients who fall
       
    • 2011-2012
      • Pharmacist-managed counseling for patients who are discharged after hematopoietic stem cell transplant
       

    Benefits

    Pharmacy residents will receive a competitive stipend for the PGY-2 residency year. Other benefits include, but are not limited to, medical and dental coverage, and MBTA discount passes.

    In addition, pharmacy residents will be invited to attend professional conferences, including:

     

    Pharmacy Residency Rotations

    The resident will spend approximately ten months completing core rotations, and is allotted two months for elective experiences and research.

    Core clinical rotations

    • Ambulatory oncology
    • Orientation and training
    • Medical oncology
    • Hematologic oncology
    • Palliative care unit
    • Stem cell transplant
    • Pediatric oncology
    • Investigational drug service

    Longitudinal experiences

    • Medication safety
    • Pharmacy administration
    • Drug information projects
    • Weekly topic discussions
    • Formulary evaluations
    • Drug use evaluations
    • Resident teaching program, if not completed during PGY-1 year
    • Teaching responsibilities at area Schools of Pharmacy
    • Formal and informal education of colleagues in nursing, pharmacy, and medicine

    Elective opportunities

    • Infectious disease
    • Anticoagulation
    • Critical care
    • Hospice
    • Women's oncology
    • Benign hematology
    • Repeat core
     

    Pharmacy Residency Preceptors

    Residency Director

    Bridget Fowler Scullion, PharmD, BCOP
    Clinical Pharmacy Manager
    Education: St. Louis College of Pharmacy

    Administration

    Sylvia B. Bartel, RPh, MHP
    Vice President of Pharmacy Services
    Education: University of Wisconsin

    Ambulatory Oncology

    Christy S. Harris, PharmD, BCPS, BCOP
    Assistant Professor – MCPHS University, Clinical Pharmacy Specialist
    Education: University of Tennessee Health Sciences

    Bone Marrow Transplant / Hematology Malignancies

    Anne McDonnell, PharmD, BCOP
    Inpatient Clinical Pharmacy Specialist
    Education: University of Arkansas for Medical Sciences

    Investigational Drug Services

    Caroline Harvey, RPh
    Research Pharmacy Manager
    Education: Northeastern University

    Medical Oncology

    Andrew Skirvin, BS, PharmD, BCOP
    Associate Clinical Professor – Northeastern University, Hematology/Oncology Clinical Pharmacist
    Education: University of Texas Health Science Center

    Medication Safety

    Audrea Szabatura, PharmD, BCOP
    Medication Safety Officer
    Education: University of Connecticut

    Pain and Palliative Care

    Victor Phantumvanit, PharmD, BCPs, BCOP
    Clinical Pharmacy Specialist
    Education: University of Maryland, School of Pharmacy

    Pediatrics

    Theresa LeFrancois, PharmD, BCOP
    Pediatric Oncology Clinical Pharmacist
    Education: Massachusetts College of Pharmacy and Health Sciences

     

    Past Residents

    2013-2014
    • Laura Perry, PharmD
      Clinical Dispensing Pharmacist, Dana-Farber Cancer Institute, Boston, MA
    • Taylor Butler, PharmD
      Assistant Professor, Nova Southeastern University, West Palm Beach, FL
    2012-2013
    • Amanda Dietzek, PharmD
      Oncology Clinical Pharmacy Manager, Einstein at Center One Pharmacy, Philadelphia, PA
    • Kelly Connelly, PharmD
      Medical Oncology Pharmacist, Yale New Haven Hospital, New Haven, CT
    2011-2012
    • Kelley Carlstrom, PharmD, BCOP
      Hematology/Oncology Clinical Pharmacy Specialist, Cleveland Clinic, Cleveland, OH
    2010-2011
    • Meredith W. H. Higley, PharmD, BCPS, BCOP
      Coordinator, Oncology Pharmacy Services, Berkshire Medical Center, Pittsfield, MA
    2009-2010
    • Houry Leblebjian, PharmD, BCOP
      Clinical Pharmacy Specialist, Dana-Farber Cancer Institute, Boston, MA
    2008-2009
    • Jian Ni, PharmD
      Hematology/Oncology Pharmacist, Brigham and Women's Hospital, Boston, MA
    2007-2008
    • Delila Katz, PharmD, BCOP
      Clinical Pharmacy Specialist, Palliative Care, Oncology, UMass Memorial Medical Center, Worcester, MA
    2006-2007
    • Victor Phantumvanit, PharmD, BCPS, BCOP
      Clinical Pharmacy Specialist, Dana-Farber Cancer Institute, Boston, MA
    2005-2006
    • Gayle Blouin, PharmD, BCOP
      Clinical Lead Pharmacist Ambulatory Oncology, Massachusetts General Hospital, Boston, MA
     

    Applying for the Pharmacy Residency

    Eligibility

    Pharm.D degree and ASHP accredited PGY1 pharmacy residency required, with experience in oncology preferred. Candidate must also be eligible for licensure in the Commonwealth of Massachusetts.

    Application procedure

    Please submit your application through PhORCAS — https://portal.phorcas.org/:

    • Letter of intent
    • Curriculum vitae
    • Three letters of recommendation

    Deadline for applying: First Friday in January
    Residency start date: First Monday following the 4th of July holiday

     

    Contact Us

    For more information, please contact:

    Bridget Fowler Scullion, PharmD
    Residency Program Director / Clinical Pharmacy Manager
    bridget_scullion@dfci.harvard.edu 

    Sylvia Bartel, RPh, MPH
    Vice President of Pharmacy
    sylvia_bartel@dfci.harvard.edu 

     
     
  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms